Global Hepatitis B Human Immunoglobulin Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 116
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 100IU

- 200IU

- 400IU

Segment by Application

- Measles Prevention

- Prevention of Hepatitis B Virus Infection

- Hepatitis A Virus Infection

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Biotest

- ADMA Biologics

- Sanquin Blood

- Bio Products Laboratory

- Baxter

- CSL

- Bayer

- Grifols

- Octapharma

- Hualan Biological

- China Biologic

- Tiantan Biologic

- Shuanglin Bio-pharmacy

- Sichuan Yuanda Shuyang

- Shanghai Institute of Biological

- Hualan

- Shanghai RAAS Blood Products

- China Grand Enterprises

- Nanyue Biopharmaceutical

- Boya Biopharmaceutical Group

- Tonglu Biopharmaceutical

- Shandong Taibang Biopharmaceutical

- Guangdong Shuanglin Biopharmaceutical

- Chengdu Rongsheng Pharmaceutical

- Shenzhen Weiguang Biopharmaceutical

- Green Cross (China) Biological Products

- Sinopharm

Global Hepatitis B Human Immunoglobulin Market Research Report 2022

Table of Contents
1 Hepatitis B Human Immunoglobulin Market Overview
1.1 Product Overview and Scope of Hepatitis B Human Immunoglobulin
1.2 Hepatitis B Human Immunoglobulin Segment by Type
1.2.1 Global Hepatitis B Human Immunoglobulin Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 100IU
1.2.3 200IU
1.2.4 400IU
1.3 Hepatitis B Human Immunoglobulin Segment by Application
1.3.1 Global Hepatitis B Human Immunoglobulin Sales Comparison by Application: (2022-2028)
1.3.2 Measles Prevention
1.3.3 Prevention of Hepatitis B Virus Infection
1.3.4 Hepatitis A Virus Infection
1.3.5 Other
1.4 Global Hepatitis B Human Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Human Immunoglobulin Revenue 2017-2028
1.4.2 Global Hepatitis B Human Immunoglobulin Sales 2017-2028
1.4.3 Hepatitis B Human Immunoglobulin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Hepatitis B Human Immunoglobulin Market Competition by Manufacturers
2.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2017-2022)
2.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Hepatitis B Human Immunoglobulin Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Hepatitis B Human Immunoglobulin Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis B Human Immunoglobulin Market Competitive Situation and Trends
2.5.1 Hepatitis B Human Immunoglobulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Human Immunoglobulin Players Market Share by Revenue
2.5.3 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Human Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.3.1 North America Hepatitis B Human Immunoglobulin Sales by Country
3.3.2 North America Hepatitis B Human Immunoglobulin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.4.1 Europe Hepatitis B Human Immunoglobulin Sales by Country
3.4.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region
3.5.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.6.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country
3.6.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country
3.7.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hepatitis B Human Immunoglobulin Historic Market Analysis by Type
4.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2022)
4.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2022)
4.3 Global Hepatitis B Human Immunoglobulin Price by Type (2017-2022)
5 Global Hepatitis B Human Immunoglobulin Historic Market Analysis by Application
5.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2022)
5.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2022)
5.3 Global Hepatitis B Human Immunoglobulin Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Biotest
6.1.1 Biotest Corporation Information
6.1.2 Biotest Description and Business Overview
6.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Biotest Hepatitis B Human Immunoglobulin Product Portfolio
6.1.5 Biotest Recent Developments/Updates
6.2 ADMA Biologics
6.2.1 ADMA Biologics Corporation Information
6.2.2 ADMA Biologics Description and Business Overview
6.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Product Portfolio
6.2.5 ADMA Biologics Recent Developments/Updates
6.3 Sanquin Blood
6.3.1 Sanquin Blood Corporation Information
6.3.2 Sanquin Blood Description and Business Overview
6.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Product Portfolio
6.3.5 Sanquin Blood Recent Developments/Updates
6.4 Bio Products Laboratory
6.4.1 Bio Products Laboratory Corporation Information
6.4.2 Bio Products Laboratory Description and Business Overview
6.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Portfolio
6.4.5 Bio Products Laboratory Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Baxter Hepatitis B Human Immunoglobulin Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.6.4 CSL Hepatitis B Human Immunoglobulin Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bayer Hepatitis B Human Immunoglobulin Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Grifols
6.8.1 Grifols Corporation Information
6.8.2 Grifols Description and Business Overview
6.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Grifols Hepatitis B Human Immunoglobulin Product Portfolio
6.8.5 Grifols Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Corporation Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Octapharma Hepatitis B Human Immunoglobulin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Hualan Biological
6.10.1 Hualan Biological Corporation Information
6.10.2 Hualan Biological Description and Business Overview
6.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Product Portfolio
6.10.5 Hualan Biological Recent Developments/Updates
6.11 China Biologic
6.11.1 China Biologic Corporation Information
6.11.2 China Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
6.11.3 China Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.11.4 China Biologic Hepatitis B Human Immunoglobulin Product Portfolio
6.11.5 China Biologic Recent Developments/Updates
6.12 Tiantan Biologic
6.12.1 Tiantan Biologic Corporation Information
6.12.2 Tiantan Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
6.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Product Portfolio
6.12.5 Tiantan Biologic Recent Developments/Updates
6.13 Shuanglin Bio-pharmacy
6.13.1 Shuanglin Bio-pharmacy Corporation Information
6.13.2 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Description and Business Overview
6.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Portfolio
6.13.5 Shuanglin Bio-pharmacy Recent Developments/Updates
6.14 Sichuan Yuanda Shuyang
6.14.1 Sichuan Yuanda Shuyang Corporation Information
6.14.2 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Description and Business Overview
6.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Portfolio
6.14.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.15 Shanghai Institute of Biological
6.15.1 Shanghai Institute of Biological Corporation Information
6.15.2 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Description and Business Overview
6.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Portfolio
6.15.5 Shanghai Institute of Biological Recent Developments/Updates
6.16 Hualan
6.16.1 Hualan Corporation Information
6.16.2 Hualan Hepatitis B Human Immunoglobulin Description and Business Overview
6.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Hualan Hepatitis B Human Immunoglobulin Product Portfolio
6.16.5 Hualan Recent Developments/Updates
6.17 Shanghai RAAS Blood Products
6.17.1 Shanghai RAAS Blood Products Corporation Information
6.17.2 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Description and Business Overview
6.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Portfolio
6.17.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.18 China Grand Enterprises
6.18.1 China Grand Enterprises Corporation Information
6.18.2 China Grand Enterprises Hepatitis B Human Immunoglobulin Description and Business Overview
6.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Product Portfolio
6.18.5 China Grand Enterprises Recent Developments/Updates
6.19 Nanyue Biopharmaceutical
6.19.1 Nanyue Biopharmaceutical Corporation Information
6.19.2 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.19.5 Nanyue Biopharmaceutical Recent Developments/Updates
6.20 Boya Biopharmaceutical Group
6.20.1 Boya Biopharmaceutical Group Corporation Information
6.20.2 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Description and Business Overview
6.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Portfolio
6.20.5 Boya Biopharmaceutical Group Recent Developments/Updates
6.21 Tonglu Biopharmaceutical
6.21.1 Tonglu Biopharmaceutical Corporation Information
6.21.2 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.21.5 Tonglu Biopharmaceutical Recent Developments/Updates
6.22 Shandong Taibang Biopharmaceutical
6.22.1 Shandong Taibang Biopharmaceutical Corporation Information
6.22.2 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.22.5 Shandong Taibang Biopharmaceutical Recent Developments/Updates
6.23 Guangdong Shuanglin Biopharmaceutical
6.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
6.23.2 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.23.5 Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
6.24 Chengdu Rongsheng Pharmaceutical
6.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information
6.24.2 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.24.5 Chengdu Rongsheng Pharmaceutical Recent Developments/Updates
6.25 Shenzhen Weiguang Biopharmaceutical
6.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information
6.25.2 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.25.5 Shenzhen Weiguang Biopharmaceutical Recent Developments/Updates
6.26 Green Cross (China) Biological Products
6.26.1 Green Cross (China) Biological Products Corporation Information
6.26.2 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Description and Business Overview
6.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Portfolio
6.26.5 Green Cross (China) Biological Products Recent Developments/Updates
6.27 Sinopharm
6.27.1 Sinopharm Corporation Information
6.27.2 Sinopharm Hepatitis B Human Immunoglobulin Description and Business Overview
6.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Sinopharm Hepatitis B Human Immunoglobulin Product Portfolio
6.27.5 Sinopharm Recent Developments/Updates
7 Hepatitis B Human Immunoglobulin Manufacturing Cost Analysis
7.1 Hepatitis B Human Immunoglobulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis B Human Immunoglobulin
7.4 Hepatitis B Human Immunoglobulin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis B Human Immunoglobulin Distributors List
8.3 Hepatitis B Human Immunoglobulin Customers
9 Hepatitis B Human Immunoglobulin Market Dynamics
9.1 Hepatitis B Human Immunoglobulin Industry Trends
9.2 Hepatitis B Human Immunoglobulin Market Drivers
9.3 Hepatitis B Human Immunoglobulin Market Challenges
9.4 Hepatitis B Human Immunoglobulin Market Restraints
10 Global Market Forecast
10.1 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Type (2023-2028)
10.2 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Application (2023-2028)
10.3 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hepatitis B Human Immunoglobulin Sales Growth Rate Comparison by Type (2022-2028) & (Litre) & (US$ Million)
Table 2. Global Hepatitis B Human Immunoglobulin Sales Growth Rate Comparison by Application (2022-2028) & (Litre) & (US$ Million)
Table 3. Global Hepatitis B Human Immunoglobulin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Hepatitis B Human Immunoglobulin Market Competitive Situation by Manufacturers in 2021
Table 5. Global Hepatitis B Human Immunoglobulin Sales (Litre) of Key Manufacturers (2017-2022)
Table 6. Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Hepatitis B Human Immunoglobulin Average Price (US$/ML) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Hepatitis B Human Immunoglobulin Manufacturing Sites and Area Served
Table 11. Manufacturers Hepatitis B Human Immunoglobulin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hepatitis B Human Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Human Immunoglobulin as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hepatitis B Human Immunoglobulin Sales by Region (2017-2022) & (Litre)
Table 16. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2017-2022)
Table 17. Global Hepatitis B Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2017-2022)
Table 19. North America Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 20. North America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 21. North America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 23. Europe Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 24. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 25. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2017-2022) & (Litre)
Table 28. Asia Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2017-2022)
Table 31. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 32. Latin America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 33. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 36. Middle East and Africa Hepatitis B Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 39. Global Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 40. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 41. Global Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Hepatitis B Human Immunoglobulin Revenue Share by Type (2017-2022)
Table 43. Global Hepatitis B Human Immunoglobulin Price by Type (2017-2022) & (US$/ML)
Table 44. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Application (2017-2022)
Table 45. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 46. Global Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Hepatitis B Human Immunoglobulin Revenue Share by Application (2017-2022)
Table 48. Global Hepatitis B Human Immunoglobulin Price by Application (2017-2022) & (US$/ML)
Table 49. Biotest Corporation Information
Table 50. Biotest Description and Business Overview
Table 51. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 52. Biotest Hepatitis B Human Immunoglobulin Product
Table 53. Biotest Recent Developments/Updates
Table 54. ADMA Biologics Corporation Information
Table 55. ADMA Biologics Description and Business Overview
Table 56. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 57. ADMA Biologics Hepatitis B Human Immunoglobulin Product
Table 58. ADMA Biologics Recent Developments/Updates
Table 59. Sanquin Blood Corporation Information
Table 60. Sanquin Blood Description and Business Overview
Table 61. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 62. Sanquin Blood Hepatitis B Human Immunoglobulin Product
Table 63. Sanquin Blood Recent Developments/Updates
Table 64. Bio Products Laboratory Corporation Information
Table 65. Bio Products Laboratory Description and Business Overview
Table 66. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 67. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product
Table 68. Bio Products Laboratory Recent Developments/Updates
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Business Overview
Table 71. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 72. Baxter Hepatitis B Human Immunoglobulin Product
Table 73. Baxter Recent Developments/Updates
Table 74. CSL Corporation Information
Table 75. CSL Description and Business Overview
Table 76. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 77. CSL Hepatitis B Human Immunoglobulin Product
Table 78. CSL Recent Developments/Updates
Table 79. Bayer Corporation Information
Table 80. Bayer Description and Business Overview
Table 81. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 82. Bayer Hepatitis B Human Immunoglobulin Product
Table 83. Bayer Recent Developments/Updates
Table 84. Grifols Corporation Information
Table 85. Grifols Description and Business Overview
Table 86. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 87. Grifols Hepatitis B Human Immunoglobulin Product
Table 88. Grifols Recent Developments/Updates
Table 89. Octapharma Corporation Information
Table 90. Octapharma Description and Business Overview
Table 91. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 92. Octapharma Hepatitis B Human Immunoglobulin Product
Table 93. Octapharma Recent Developments/Updates
Table 94. Hualan Biological Corporation Information
Table 95. Hualan Biological Description and Business Overview
Table 96. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 97. Hualan Biological Hepatitis B Human Immunoglobulin Product
Table 98. Hualan Biological Recent Developments/Updates
Table 99. China Biologic Corporation Information
Table 100. China Biologic Description and Business Overview
Table 101. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 102. China Biologic Hepatitis B Human Immunoglobulin Product
Table 103. China Biologic Recent Developments/Updates
Table 104. Tiantan Biologic Corporation Information
Table 105. Tiantan Biologic Description and Business Overview
Table 106. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 107. Tiantan Biologic Hepatitis B Human Immunoglobulin Product
Table 108. Tiantan Biologic Recent Developments/Updates
Table 109. Shuanglin Bio-pharmacy Corporation Information
Table 110. Shuanglin Bio-pharmacy Description and Business Overview
Table 111. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 112. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product
Table 113. Shuanglin Bio-pharmacy Recent Developments/Updates
Table 114. Sichuan Yuanda Shuyang Corporation Information
Table 115. Sichuan Yuanda Shuyang Description and Business Overview
Table 116. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 117. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product
Table 118. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 119. Shanghai Institute of Biological Corporation Information
Table 120. Shanghai Institute of Biological Description and Business Overview
Table 121. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 122. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product
Table 123. Shanghai Institute of Biological Recent Developments/Updates
Table 124. Hualan Corporation Information
Table 125. Hualan Description and Business Overview
Table 126. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 127. Hualan Hepatitis B Human Immunoglobulin Product
Table 128. Hualan Recent Developments/Updates
Table 129. Shanghai RAAS Blood Products Corporation Information
Table 130. Shanghai RAAS Blood Products Description and Business Overview
Table 131. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 132. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product
Table 133. Shanghai RAAS Blood Products Recent Developments/Updates
Table 134. China Grand Enterprises Corporation Information
Table 135. China Grand Enterprises Description and Business Overview
Table 136. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 137. China Grand Enterprises Hepatitis B Human Immunoglobulin Product
Table 138. China Grand Enterprises Recent Developments/Updates
Table 139. Nanyue Biopharmaceutical Corporation Information
Table 140. Nanyue Biopharmaceutical Description and Business Overview
Table 141. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 142. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 143. Nanyue Biopharmaceutical Recent Developments/Updates
Table 144. Boya Biopharmaceutical Group Corporation Information
Table 145. Boya Biopharmaceutical Group Description and Business Overview
Table 146. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 147. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product
Table 148. Boya Biopharmaceutical Group Recent Developments/Updates
Table 149. Tonglu Biopharmaceutical Corporation Information
Table 150. Tonglu Biopharmaceutical Description and Business Overview
Table 151. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 152. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 153. Tonglu Biopharmaceutical Recent Developments/Updates
Table 154. Shandong Taibang Biopharmaceutical Corporation Information
Table 155. Shandong Taibang Biopharmaceutical Description and Business Overview
Table 156. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
  • Global Sickle Cell Anemia Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 122
    Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sickle Cell Anemia Therapeutics mark......
  • Global Pharma and Cetirizine OTC Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 130
    Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Pharma and Cetirizine OTC market is projected to reach US$ million by 2028 from an estimated US$ million in......
  • Global Neurological Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 125
    A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neurological Biomarkers market is projected to re......
  • Global Infertility Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 97
    Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Infertility Drugs market is projected to reach US$ 7494.8 million by 2028 from an estim......
  • Global Herbal Medicinal Products Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 131
    Herbal Medicinal Products--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of Herbal Medicinal Products in the treating and preventing disease. Highlights Considering the ec......
  • Global Fertility Enhancing Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Fertility Enhancing Treatment market is projected to reach US$ 7577.7 million by 2028 f......
  • Global Duchenne Muscular Dystrophy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 107
    uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respi......
  • Global Dry Eye Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 118
    Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Dr......
  • Global Disinfectant Gels Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 22-Sep-2022        Price: US 5900 Onwards        Pages: 105
    Disinfectant Gels Alcohol-based disinfectant gels (perhaps better termed hand antiseptics) have recently become increasingly popular for hand disinfection, as an alternative to handwashing with soap and water, and in order to improve hand hygiene. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Disinfectant Gels market is projected to reach US$ 242.7 million by 2028 from an estimated US$ 175 million in 2022, at a CAGR ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs